This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Timing profit-taking in retirement rebalancing helps lock in gains while preserving the plan. This guide highlights practical timing cues and rules.
17,033 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Ripple's latest private-market move values the company at $50 billion and signals confidence in its ecosystem, even a...
Oilfield services stocks led by Baker Hughes, Halliburton, and Transocean each rose around 5% as crude oil prices jum...
Rising college costs push families to mix aid, savings, and careful borrowing. This report breaks down how to evaluat...
New York's transit agency filed a federal lawsuit against the federal government after nearly $60 million in subway f...
Choosing between REET and RWX can shape your global real estate exposure. This guide breaks down costs, diversificati...
Quantum computing could reshape industries, and early investors may gain. This guide breaks down three stocks to watc...
A sharp move in a gold royalty stock can trigger questions for both traders and long-term investors. This article bre...
Starting July 2026, the federal loan cap for professional programs changes how families fund education. Clark Howard’...
A missile strike on Qatar’s LNG facilities pushes oil and gas markets higher. Traders point to wall street buying the...
What could Nvidia's stock do by the end of 2026? This article lays out clear scenarios, key drivers, and practical ti...
Investors weigh growth plans and political headlines as DJT faces a volatile path to profitability, with forecasts sp...